HA
ASND icon

HC Advisors’s Ascendis Pharma A/S ASND Stock Holding History

HC Advisors’s Portfolio ASND Stock Details ASND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-1,479
Closed -$224K – 52
2024
Q1 		$224K Buy
+1,479
New +$211K 0.11% 83
2023
Q1 		– Sell
-2,075
Closed -$253K – 82
2022
Q4 		$253K Sell
2,075
-500
-19% -$58.1K 0.17% 66
2022
Q3 		$266K Sell
2,575
-71
-3% -$6.73K 0.18% 66
2022
Q2 		$246K Buy
2,646
+2
+0.1% +$188 0.18% 64
2022
Q1 		$310K Sell
2,644
-292
-10% -$33.8K 0.2% 62
2021
Q4 		$395K Buy
2,936
+565
+24% +$84K 0.24% 52
2021
Q3 		$378K Sell
2,371
-84
-3% -$11.5K 0.25% 51
2021
Q2 		$323K Sell
2,455
-92
-4% -$12.3K 0.2% 57
2021
Q1 		$328K Buy
2,547
+50
+2% +$7.6K 0.21% 54
2020
Q4 		$416K Buy
2,497
+192
+8% +$31.8K 0.28% 50
2020
Q3 		$356K Buy
2,305
+258
+13% +$37.1K 0.29% 46
2020
Q2 		$303K Buy
+2,047
New +$281K 0.25% 62

Other funds holding ASND

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

HC Advisors's ASND Position: Q2 2024 in Review

HC Advisors sold out of Ascendis Pharma A/S (ASND) in Q2 2024, closing a stake of 1,479 shares — an estimated $224K sold.

HC Advisors first reported a position in ASND in Q2 2020 and held it in 12 quarters. The position peaked at $416K in Q4 2020. 203 funds tracked by Wall St. Rank hold ASND as of Q2 2024.

  • HC Advisors reported no remaining Ascendis Pharma A/S position as of Q2 2024 after selling out during the quarter.
  • HC Advisors sold 1,479 Ascendis Pharma A/S shares in Q2 2024, an estimated $224K.
  • HC Advisors first reported a position in Ascendis Pharma A/S in Q2 2020 and held it in 12 quarters.
  • HC Advisors's Ascendis Pharma A/S position peaked at $416K in Q4 2020.
  • 203 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q2 2024.

Based on HC Advisors's 13F filing for Q2 2024, filed 7 Aug 2024.